These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 17075777

  • 1. Blood-soluble Fas levels are increased in type 2 diabetic patients with peripheral vascular disease.
    García-Unzueta MT, Pesquera C, Calzada E, De la Mora A, Muñoz P, Llorca J, Morchón N, Fernández-González MD, Amado JA.
    Horm Metab Res; 2006 Oct; 38(10):673-7. PubMed ID: 17075777
    [Abstract] [Full Text] [Related]

  • 2. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI, Sheu WH, Song YM, Liu HC, Lee WJ, Chen YT.
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [Abstract] [Full Text] [Related]

  • 3. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E.
    J Diabetes Complications; 2005 Apr; 19(1):42-6. PubMed ID: 15642489
    [Abstract] [Full Text] [Related]

  • 4. Increased levels of soluble Fas in serum from diabetic patients with neuropathy.
    Guillot R, Bringuier AF, Porokhov B, Guillausseau PJ, Feldmann G.
    Diabetes Metab; 2001 Jun; 27(3):315-21. PubMed ID: 11431596
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons.
    Katsilambros NL, Tsapogas PC, Arvanitis MP, Tritos NA, Alexiou ZP, Rigas KL.
    Diabet Med; 1996 Mar; 13(3):243-6. PubMed ID: 8689845
    [Abstract] [Full Text] [Related]

  • 6. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.
    Hébert MJ, Masse M, Vigneault N, Sirois I, Troyanov S, Madore F.
    Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of peripheral vascular disease in sulfonylurea treated diabetic patients with proteinuria.
    Migdalis IN, Kourti A, Voudouris G, Likoudi A, Samartzis M.
    Int Angiol; 1990 Dec; 9(4):271-3. PubMed ID: 2099962
    [Abstract] [Full Text] [Related]

  • 8. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H, Liu ZM, Li GW, Guo XH, Xu ZR, Zou DJ, Xing HL, Liu W, Sheng ZY, Tian HM, Zhu DL, Yu DM, Zhuang WT, Chen LL, Weng JP.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 02; 87(1):23-7. PubMed ID: 17403307
    [Abstract] [Full Text] [Related]

  • 9. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E, Baccara-Dinet M, Eschwege E.
    Diabet Med; 2007 Apr 02; 24(4):388-91. PubMed ID: 17335463
    [Abstract] [Full Text] [Related]

  • 10. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2009 Oct 02; 19(8):580-6. PubMed ID: 19196499
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R, Mohan A, Rema M, Haranath SP, Saravanan G, Mohan V.
    J Assoc Physicians India; 2002 May 02; 50(5):657-61. PubMed ID: 12186119
    [Abstract] [Full Text] [Related]

  • 12. Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease.
    Boulbou MS, Koukoulis GN, Vasiou KG, Petinaki EA, Gourgoulianis KI, Fezoulidis IB.
    Int Angiol; 2004 Mar 02; 23(1):18-24. PubMed ID: 15156125
    [Abstract] [Full Text] [Related]

  • 13. Comparison of colour duplex ultrasound and ankle-brachial pressure index measurements in peripheral vascular disease in type 2 diabetic patients with foot infections.
    Premalatha G, Ravikumar R, Sanjay R, Deepa R, Mohan V.
    J Assoc Physicians India; 2002 Oct 02; 50():1240-4. PubMed ID: 12568206
    [Abstract] [Full Text] [Related]

  • 14. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.
    Wadwa RP, Kinney GL, Ogden L, Snell-Bergeon JK, Maahs DM, Cornell E, Tracy RP, Rewers M.
    Int J Biochem Cell Biol; 2006 Oct 02; 38(5-6):996-1003. PubMed ID: 16271309
    [Abstract] [Full Text] [Related]

  • 15. Hypertriglyceridemia in insulin dependent diabetes mellitus with peripheral vascular disease.
    Vogelberg KH, Grimm K, Gries FA.
    Horm Metab Res Suppl; 1985 Oct 02; 15():90-4. PubMed ID: 3865888
    [Abstract] [Full Text] [Related]

  • 16. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?
    Shargorodsky M, Boaz M, Pasternak S, Hanah R, Matas Z, Fux A, Beigel Y, Mashavi M.
    Diabetes Metab Res Rev; 2009 Jan 02; 25(1):70-5. PubMed ID: 19065546
    [Abstract] [Full Text] [Related]

  • 17. Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.
    Janka HU, Ziegler AG, Standl E, Mehnert H.
    Diabete Metab; 1987 Jul 02; 13(3 Pt 2):359-64. PubMed ID: 3308565
    [Abstract] [Full Text] [Related]

  • 18. Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings.
    Baba K, Minatoguchi S, Sano H, Kagawa T, Murata I, Takemura G, Hirano T, Ohashi H, Takemura M, Fujiwara T, Fujiwara H.
    Nephrology (Carlton); 2004 Apr 02; 9(2):94-9. PubMed ID: 15056269
    [Abstract] [Full Text] [Related]

  • 19. Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus.
    Endo K, Oyama T, Saiki A, Ban N, Ohira M, Koide N, Murano T, Watanabe H, Nishii M, Miura M, Sekine K, Miyashita Y, Shirai K.
    Diabetes Res Clin Pract; 2008 Apr 02; 80(1):63-8. PubMed ID: 18207277
    [Abstract] [Full Text] [Related]

  • 20. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
    Sahli D, Eriksson JW, Boman K, Svensson MK.
    Thromb Res; 2009 Mar 02; 123(5):701-6. PubMed ID: 18945481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.